4.5 Article

18F-Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts

Journal

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
Volume 2012, Issue 5, Pages 889-892

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejoc.201101730

Keywords

Sulfonium salts; Fluorine; Isotopic labeling; Density functional calculations

Funding

  1. Eidgenossische Technische Hochschule (ETH) [FEL-01 10-1]

Ask authors/readers for more resources

A new method for the 18F-radiolabeling of aromatic compounds based on the aromatic nucleophilic substitution (SNAr) reaction using triarylsulfonium salts has been developed. Experiments and DFT calculations indicated that sulfonium ions have the potential to be optimized for labeling nonactivated and deactivated aryl rings that have Hammett sP substituent constants greater than 0.170. This method is applicable to a range of halogen-substituted aryl systems including nonactivated and deactivated aryl rings. In particular, the high radiochemical yield of [18F]-4-fluoroiodobenzene from precursor 1a represents a ready source of compound 1b for subsequent use in palladium-catalyzed CH activation/CC bond-forming reactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Role of sex hormones in modulating myocardial perfusion and coronary flow reserve

Ahmed Haider, Susan Bengs, Angela Portmann, Alexia Rossi, Hazem Ahmed, Dominik Etter, Geoffrey Warnock, Nidaa Mikail, Muriel Gramer, Alexander Meisel, Livio Gisler, Caitlin Jie, Claudia Keller, Sebastian Kozerke, Bruno Weber, Roger Schibli, Linjing Mu, Philipp A. Kaufmann, Vera Regitz-Zagrosek, Simon M. Ametamey, Catherine Gebhard

Summary: This study aimed to assess the impact of female and male sex hormones on myocardial perfusion and coronary flow reserve. The experimental data in mice indicate that testosterone plays a primary role in sex differences in myocardial perfusion.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Cardiac & Cardiovascular Systems

Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice

Susan Bengs, Geoffrey Warnock, Angela Portmann, Nidaa Mikail, Alexia Rossi, Hazem Ahmed, Dominik Etter, Valerie Treyer, Livio Gisler, Stefanie K. Pfister, Caitlin V. M. L. Jie, Alexander Meisel, Claudia Keller, Steven H. Liang, Roger Schibli, Linjing Mu, Ronny R. Buechel, Philipp A. Kaufmann, Simon M. Ametamey, Catherine Gebhard, Ahmed Haider

Summary: This study demonstrates the feasibility of using F-18-flurpiridaz for simplified assessment of relative myocardial perfusion and coronary flow reserve in mice, enabling high-throughput mechanistic CFR studies in rodents.

JOURNAL OF NUCLEAR CARDIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Signaling Network Response to a-Particle-Targeted Therapy with the 225Ac-Labeled Minigastrin Analog 225Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors

Yun Qin, Stefan Imobersteg, Stephan Frank, Alain Blanc, Tanja Chiorazzo, Philipp Berger, Roger Schibli, Martin P. Behe, Michal Grzmil

Summary: α-particle emitters have potential as therapeutic radionuclides, but toxicity and radioresistance limit their efficacy. This study identified the radiation-activated mechanisms driving cancer cell survival, providing opportunities for therapeutic interference to improve the efficacy and safety of α-particle therapy.

JOURNAL OF NUCLEAR MEDICINE (2023)

Review Oncology

Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer

Michal Grzmil, Fabius Wiesmann, Roger Schibli, Martin Behe

Summary: Targeted radionuclide therapy (TRT) is a cancer treatment that delivers cancer-selective radiopharmaceuticals to destroy cancer cells without harming healthy tissue. This review focuses on the use of mTORC1 inhibition to improve the efficacy of TRT by delivering radiolabeled ligands. It discusses the rationale, efficacy, and safety of this combinatorial approach in cancer patients.

CANCERS (2023)

Article Chemistry, Medicinal

In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143

Melanie Zechner, Claudia A. Castro Jaramillo, Nadine S. Zubler, Marco F. Taddio, Linjing Mu, Karl-Heinz Altmann, Stefanie D. Kramer

Summary: Breast cancer resistance protein (BCRP, ABCG2) is a crucial efflux transporter involved in multidrug resistance to antineoplastic drugs. Ko143, an analogue of fumitremorgin C, is a potent ABCG2 inhibitor but is rapidly metabolized in vivo. In order to find ABCG2 inhibitors with improved metabolic stability, a series of Ko143 analogues were evaluated for their ability to inhibit ABCG2-mediated transport in cells and assessed for stability in liver microsomes. The most promising analogues increased the distribution of [11C]tariquidar, an ABCG2/ABCB1 substrate, to the brain in animal models.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

161Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of 161Tb into the Clinic

Chiara Favaretto, Pascal Grundler, Zeynep Talip, Stefan Landolt, Lebogang Sepini, Ulli Koster, Cristina Muller, Roger Schibli, Susanne Geistlich, Nicholas P. van der Meulen

Summary: This study aimed to characterize and specify 161Tb, as well as develop a protocol for the synthesis and quality control of 161Tb-DOTATOC for clinical use. Results showed that 161Tb met the clinical requirements in terms of chemical purity, radionuclidic purity, and endotoxin level. A highly efficient procedure for the automated production and quality control of 161Tb-DOTATOC was developed. This study provides valuable insights for the application of 161Tb in radionuclide therapy.

JOURNAL OF NUCLEAR MEDICINE (2023)

Article Medicine, Research & Experimental

Inductively Coupled Plasma Mass Spectrometry-A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals

Rahel H. Wallimann, Patrick Schindler, Heloise Hensinger, Viviane J. Tschan, Sarah D. Busslinger, Rainer Kneuer, Cristina Muller, Roger Schibli

Summary: The study investigates whether inductively coupled plasma mass spectrometry (ICP-MS) can be used to predict the properties of radiopharmaceuticals by characterizing non-radioactive metal conjugates. The results show that ICP-MS and conventional gamma-counting provide almost identical results for in vitro and in vivo uptake and internalization of the metal conjugates. Therefore, ICP-MS can be considered as a reliable alternative to gamma-counting for the detection and quantification of radioactive ligands.

MOLECULAR PHARMACEUTICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides

Darja Beyer, Christian Vaccarin, Xavier Deupi, Ana Katrina Mapanao, Susan Cohrs, Fan Sozzi-Guo, Pascal V. Grundler, Nicholas P. van der Meulen, Jinling Wang, Matthias Tanriver, Jeffrey W. Bode, Roger Schibli, Cristina Mueller

Summary: This study developed an ACE2-targeting imaging agent to determine ACE2 regulation. The radiopeptide [Ga-67]Ga-HBED-CC-DX600 showed the most favorable tissue distribution profile.

EJNMMI RESEARCH (2023)

Article Chemistry, Multidisciplinary

Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers

Faustine d'Orchymont, Jason P. Holland

Summary: We synthesized and characterized bimodal mechanically interlocked rotaxane-based imaging agents using the cucurbit[6]uril CB[6]-mediated alkyne-azide 'click' reaction. Two synthetic routes involving four- or six-component reactions were developed to access asymmetric rotaxanes. A peptide-based rotaxane targeted toward the clinical prostate cancer biomarker, prostate-specific membrane antigen (PSMA), was synthesized with Ga-68-radiometal ion complex for positron emission tomography and fluorescein as an optically active imaging agent. The results showed the feasibility of using an asymmetric rotaxane platform to produce dual-modality imaging agents specifically targeting prostate cancer cells.

COMMUNICATIONS CHEMISTRY (2023)

Article Chemistry, Inorganic & Nuclear

HNODThia: A Promising Chelator for the Development of Cu-64 Radiopharmaceuticals

Ina Hierlmeier, Amaury Guillou, Daniel F. Earley, Anthony Linden, Jason P. Holland, Mark D. Bartholomae

Summary: In this study, we synthesized and investigated the coordination chemistry of novel copper(II) and zinc(II) complexes using two heterocyclic triazacyclononane(tacn)-based chelators (HNODThia and NODThia-AcNHEt). The modified chelator HNODThia was used to develop a PSMA-based bioconjugate (NODThia-PSMA) and a photoactivatable azamacrocyclic analogue (NODThia-PEG ( 3 ) -ArN ( 3 )) for copper-64 radiopharmaceuticals. The metal-binding chelates showed rapid radiolabeling, stability in human plasma, and successful photoconjugation to albumin and antibodies. These findings have significant implications for the development of stable Cu-64-based radiopharmaceuticals and the future application of Cu-67 in targeted radioimmunotherapy.

INORGANIC CHEMISTRY (2023)

Article Oncology

Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates

Sarah D. Busslinger, Anna E. Becker, Christian Vaccarin, Luisa M. Deberle, Marie-Luise Renz, Viola Groehn, Roger Schibli, Cristina Muller

Summary: This study revealed that modification with an albumin-binding moiety can enhance blood residence time of radiopharmaceuticals, affecting their tissue distribution profiles. Different albumin binders and linker units can fine-tune the pharmacokinetic properties of radioconjugates for optimal tumor uptake and distribution. Subtle changes in the albumin-binding entity and linker unit can lead to significant differences in blood retention and kidney accumulation of radiopharmaceuticals.

CANCERS (2023)

Article Agriculture, Dairy & Animal Science

Impact of Surgical Lights on the Performance of Fluorescence-Guided Surgery Systems: A Pilot Study

Lavinia E. Chiti, Brian Park, Faustine d'Orchymont, Jason P. Holland, Mirja C. Nolff

Summary: The use of near-infrared fluorophores has promising applications in surgical oncology. The performance of dedicated camera systems is affected by the lighting condition of the operating theatre. LED and halogen lights have a detrimental effect on the diagnostic performances of the camera systems. Surgeons should evaluate the spectral contribution of the lights when implementing fluorescence-guided surgery (FGS) into the clinical routine.

ANIMALS (2023)

Article Biochemistry & Molecular Biology

Designed ankyrin repeat proteins for detecting prostate-specific antigen expression in vivo

Melanie Gut, Birgit Dreier, Sven Furler, Jens Sobek, Andreas Pluckthun, Jason P. Holland

Summary: Late-stage prostate cancer often becomes resistant to standard chemotherapy and transforms into a hormone-resistant, drug-resistant, and incurable disease. Developing non-invasive tools to detect biochemical changes that indicate drug efficacy and identify drug resistance could have significant implications in managing individual patients' treatment plans. In this study, new Designed Ankyrin Repeat Proteins (DARPins) with high affinity for prostate-specific antigen (PSA) were selected using ribosome display and in vitro screening tools. These PSAbinding DARPins showed nanomolar affinity for PSA and could be radiolabeled for potential use in imaging-based monitoring of androgen receptor (AR)-targeted therapies.

RSC CHEMICAL BIOLOGY (2023)

Article Biochemical Research Methods

Proof-of-concept optimization of a copper-mediated 18F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation

Yingqing Lu, Yingfang He, Roger Schibli, Linjing Mu, R. Michael van Dam

Summary: Copper-mediated radiofluorination has great potential in the synthesis of PET radioligands. We demonstrated the feasibility of Cu-mediated radiosynthesis on a high-throughput microdroplet platform and optimized the reaction conditions. By utilizing microscale conditions, we achieved higher radiochemical yield and excellent radiochemical purity and molar activity. We also successfully translated these optimized conditions to a vial-based method, expanding the applicability of the synthesis approach.

LAB ON A CHIP (2023)

No Data Available